At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 24 enrolled
Drug / intervention
flibanserin 100 mg dose every eveningdrug
Likely dose
flibanserin 100 mg dose every eveningfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation of Single Dose and Steady State Pharmacokinetics of Flibanserin Postmenopausal Women With Hypoactive Sexual Desire Disorder
In Brief
A Phase 1 clinical trial evaluating flibanserin 100 mg dose every evening for Sexual Dysfunctions, Psychological. Completed, enrolled 24 participants across 4 sites.
Detailed Summary
This trial examines the way flibanserin is metabolized in postmenopausal women with Hypoactive Sexual Desire Disorder.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSexual Dysfunctions, Psychological
CountriesUnited States
Collaborators--
Timeline
Phase 1CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartJul 2010
First PostedAug 2010
Primary CompletionOct 2010
TodayJul 2026
First PostedAug 25, 2010
Enrollment StartJul 1, 2010
Primary CompletionOct 1, 2010
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 15.9 years ago
Interventions
flibanserin 100 mg dose every eveningdrug
all subjects receive flibanserin